Artificial intelligence is emerging as a promising tool for improving eye care for people living with diabetes. New research suggests that using AI-assisted screening to identify diabetic retinopathy may encourage more patients to attend the specialist appointments needed to protect their vision.

Diabetic retinopathy is an eye condition caused by damage to the small blood vessels in the retina. It can develop in people with diabetes and may lead to serious vision problems if it progresses without appropriate medical attention.

Why Early Detection Matters

People with diabetes face an increased risk of developing retinal damage, particularly when blood glucose levels remain elevated over long periods. The condition can progress without noticeable symptoms during its early stages, making regular eye examinations essential.

Traditional screening programmes can identify people who may need further assessment. However, some patients do not complete the recommended follow-up appointments, creating gaps between initial detection and specialist treatment.

AI-assisted screening could help address this challenge by making the initial assessment process more accessible and identifying patients who may require additional care.

How Artificial Intelligence Supports Eye Screening

AI systems can analyse retinal photographs and identify patterns associated with diabetic retinopathy. Depending on the system and its regulatory approval, the technology may help healthcare professionals determine whether a patient needs further examination by an eye specialist.

In some settings, AI-assisted screening can be offered through primary-care clinics or other locations where patients already receive diabetes-related services. This may reduce practical barriers to screening and help identify potential eye problems earlier.

The technology is designed to support clinical care rather than replace every aspect of an ophthalmologist’s examination. Patients with concerning results may still require specialist assessment, additional imaging or treatment.

Follow-Up Attendance Could Improve

Research examining AI-based diabetic retinopathy screening has reported that patients receiving this type of screening were more likely to complete subsequent specialist examinations than patients receiving conventional screening.

The reported difference was approximately twofold in the study described in the initial research summary. This suggests that the screening method and the way results are communicated may influence whether patients proceed to the next stage of care.

However, improved attendance does not automatically mean that every patient receives treatment sooner or experiences better vision outcomes. Those questions require further evaluation.

Potential Benefits for Healthcare Systems

AI-assisted screening could offer several advantages when integrated into well-designed healthcare programmes.

• Earlier identification: Potential signs of retinal damage may be detected before severe symptoms appear.
• Improved access: Screening may become more available in settings with limited access to eye specialists.
• Better care coordination: Clearer screening results may help healthcare teams direct patients toward appropriate follow-up services.
• More efficient screening: Automated analysis may help healthcare professionals manage large numbers of retinal images.

The effectiveness of these benefits depends on the accuracy of the AI system, the quality of retinal images, access to specialist services and whether patients can complete the recommended care.

AI Cannot Replace Regular Medical Care

People with diabetes should continue to follow their healthcare professional’s recommendations for retinal screening, even when they have no changes in vision. Screening intervals depend on individual risk factors, previous examination results and clinical guidance.

Anyone experiencing sudden vision loss, a sudden increase in floaters or flashes of light should seek urgent eye-care assessment rather than wait for a routine screening appointment.

AI-based eye screening offers a potential way to strengthen diabetes care by helping more patients move from detection to specialist evaluation. Further research will determine how consistently these systems improve follow-up attendance and whether those improvements translate into better long-term vision outcomes.